These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 16284877

  • 21. Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells.
    Arvans D, Jung YC, Antonopoulos D, Koval J, Granja I, Bashir M, Karrar E, Roy-Chowdhury J, Musch M, Asplin J, Chang E, Hassan H.
    J Am Soc Nephrol; 2017 Mar; 28(3):876-887. PubMed ID: 27738124
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
    Peck AB, Canales BK, Nguyen CQ.
    Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
    [Abstract] [Full Text] [Related]

  • 25. Oxalobacter formigenes: A new hope as a live biotherapeutic agent in the management of calcium oxalate renal stones.
    Hiremath S, Viswanathan P.
    Anaerobe; 2022 Jun; 75():102572. PubMed ID: 35443224
    [Abstract] [Full Text] [Related]

  • 26. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes.
    Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB.
    J Urol; 2001 Oct; 166(4):1487-91. PubMed ID: 11547118
    [Abstract] [Full Text] [Related]

  • 27. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
    Canales BK, Hatch M.
    Surg Obes Relat Dis; 2017 Jul; 13(7):1152-1157. PubMed ID: 28552742
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion.
    Hatch M, Freel RW.
    Urolithiasis; 2013 Oct; 41(5):379-84. PubMed ID: 23959075
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P, Niedźwiadek J, Mazur E, Paluch-Oleś J, Zajaczkowska M, Kozioł-Montewka M.
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [Abstract] [Full Text] [Related]

  • 34. Oxalate-degrading Enterococcus faecalis.
    Hokama S, Honma Y, Toma C, Ogawa Y.
    Microbiol Immunol; 2000 Jul; 44(4):235-40. PubMed ID: 10832966
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.
    Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A.
    Front Biosci; 2003 Sep 01; 8():e437-43. PubMed ID: 12957811
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW, Choy D, Penniston KL, Lange D.
    Kidney Int; 2019 Jul 01; 96(1):180-188. PubMed ID: 31130222
    [Abstract] [Full Text] [Related]

  • 37. Oxalate-degrading Providencia rettgeri isolated from human stools.
    Hokama S, Toma C, Iwanaga M, Morozumi M, Sugaya K, Ogawa Y.
    Int J Urol; 2005 Jun 01; 12(6):533-8. PubMed ID: 15985073
    [Abstract] [Full Text] [Related]

  • 38. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
    Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H.
    Kidney Int; 2006 Oct 01; 70(7):1305-11. PubMed ID: 16850020
    [Abstract] [Full Text] [Related]

  • 39. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.
    Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR.
    J Appl Microbiol; 2012 Aug 01; 113(2):418-28. PubMed ID: 22616725
    [Abstract] [Full Text] [Related]

  • 40. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.
    Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H.
    Int J Urol; 2003 Jun 01; 10(6):293-6. PubMed ID: 12757596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.